Page last updated: 2024-10-31

acecainide and Cerebrovascular Disorders

acecainide has been researched along with Cerebrovascular Disorders in 1 studies

Acecainide: A major metabolite of PROCAINAMIDE. Its anti-arrhythmic action may cause cardiac toxicity in kidney failure.
N-acetylprocainamide : A benzamide obtained via formal condensation of 4-acetamidobenzoic acid and 2-(diethylamino)ethylamine.

Cerebrovascular Disorders: A spectrum of pathological conditions of impaired blood flow in the brain. They can involve vessels (ARTERIES or VEINS) in the CEREBRUM, the CEREBELLUM, and the BRAIN STEM. Major categories include INTRACRANIAL ARTERIOVENOUS MALFORMATIONS; BRAIN ISCHEMIA; CEREBRAL HEMORRHAGE; and others.

Research Excerpts

ExcerptRelevanceReference
"Nineteen patients whose arrhythmias were initially suppressed with acetylprocainamide underwent long-term treatment with this drug."3.66Long-term antiarrhythmic therapy with acetylprocainamide. ( Drayer, DE; Kluger, J; Leech, S; Lloyd, V; Reidenberg, MM, 1981)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Kluger, J1
Leech, S1
Reidenberg, MM1
Lloyd, V1
Drayer, DE1

Other Studies

1 other study available for acecainide and Cerebrovascular Disorders

ArticleYear
Long-term antiarrhythmic therapy with acetylprocainamide.
    The American journal of cardiology, 1981, Volume: 48, Issue:6

    Topics: Acecainide; Acetylation; Adult; Aged; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Arthritis, Rheum

1981